Envoy Medical Reaches Six-Month Milestone in Acclaim Cochlear Implant Pivotal Trial

Envoy Medical, Inc. has reached the six-month follow-up milestone in its pivotal clinical trial for the Acclaim fully implanted cochlear implant, marking a significant point in the trial's final data collection phase. The company is on track to complete the 12-month follow-up visits by early Q2 2027 and plans to submit the final clinical Premarket Approval (PMA) module by the end of Q2 2027. Envoy Medical claims to be the first to achieve this milestone in a U.S. pivotal trial for a fully implanted cochlear implant.